Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sensory Recovery of Reconstructed Breast With Breast Reconstructive Options

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03535012
Recruitment Status : Unknown
Verified May 2018 by Yonsei University.
Recruitment status was:  Recruiting
First Posted : May 24, 2018
Last Update Posted : May 25, 2018
Sponsor:
Information provided by (Responsible Party):
Yonsei University

Brief Summary:

Over the past 10 years, there have been substantial improvements in breast reconstruction by plastic surgeons, and much has been achieved in aesthetic restoration after mastectomy. Advances in both microsurgery and implants have allowed for a wider variety of surgical methods, and procedural skills that minimize donor site complications have been developed.

With such satisfactory aesthetic results, interest has recently increased not only in breast reconstruction but also in sensory recovery. Due to the growing expectation of patients, sensory discomfort may decrease overall patient satisfaction with breast reconstruction despite good aesthetic results. Hence, for qualitative improvement of breast reconstruction surgery, efforts must be made to restore sensation in the reconstructed breast. There has been little research on the mechanism of sensory recovery despite its clinical importance. This study aimed to compare the degree of sensory recovery in the reconstructed breast using various reconstruction methods as well as to evaluate the status of neural regeneration with harvesting the tissues when nipple reconstruction is performed.


Condition or disease
Breast Cancer

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sensory Recovery of Reconstructed Breast With Breast Reconstructive Options
Actual Study Start Date : September 1, 2016
Estimated Primary Completion Date : February 28, 2020
Estimated Study Completion Date : February 28, 2020

Resource links provided by the National Library of Medicine


Group/Cohort
Reconstruction using an implant
Immediate 2 stage implant based breast reconstruction after mastectomy. All expanders are placed in the subpectoralis muscle using ADM as a sling. After expansion of the tissue expander change to the permanent implant is performed.
Reconstruction using abdominal tissue
immediate free DIEP flap breast reconstruction after mastectomy. DIEP(deep inferior epigastric perforator) free flap was prepared and transferred to the breast pocket. Microanastomosis was done under the microscopic magnification. On sitting position, free flap was inset into breast pocket with confirming of satisfactory inflammatory fold.



Primary Outcome Measures :
  1. Sensory recovery in the reconstructed breast according to reconstructive options [ Time Frame: 3 months (±1 month) after immediate breast reconstruction surgery ]
    Subjects will be followed up with quantitative sensory testing at 3 months (±1 month) after immediate breast reconstruction surgery.

  2. Sensory recovery in the reconstructed breast according to reconstructive options [ Time Frame: 6 months (±1 month) after immediate breast reconstruction surgery ]
    Subjects will be followed up with quantitative sensory testing at 6 months (±1 month) after immediate breast reconstruction surgery.

  3. Sensory recovery in the reconstructed breast according to reconstructive options [ Time Frame: 12 months (±2 months) after immediate breast reconstruction surgery ]
    Subjects will be followed up with quantitative sensory testing at 12 months (±2 months) after immediate breast reconstruction surgery.

  4. Sensory recovery in the reconstructed breast according to reconstructive options [ Time Frame: 18 months (±2 months) after immediate breast reconstruction surgery ]
    Subjects will be followed up with quantitative sensory testing at 18 months (±2 months) after immediate breast reconstruction surgery.


Biospecimen Retention:   Samples Without DNA
A sample of 5 mm3 including skin tissue from the flap for reconstruction at the time of immediate breast reconstruction A sample of 5 mm3 including skin tissue at the time of nipple reconstruction (nipple reconstruction will be performed at the time requested by the subject)


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
This study will be conducted by dividing the subjects into two groups(25 per each arm) according to the method of reconstruction: implant vs. abdominal tissue. It is difficult to determine a sample size that can establish statistical significance based on previous studies. Therefore, the number of targeted subjects was estimated based on the number of patients that can generally be recruited during the study period.
Criteria

Inclusion Criteria:

  • Female adults over 20 years of age
  • Patients who have undergone or plan to undergo total mastectomy and immediate breast reconstruction after the diagnosis of breast cancer (including carcinoma in situ)
  • written consent to study participation

Exclusion Criteria:

  • presence of neuropathy that may hinder accurate assessment of sensation
  • presence of dermatological condition that may hinder accurate assessment of sensation
  • inability to provide written consent
  • decided by the research team to be unsuitable for this study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03535012


Locations
Layout table for location information
Korea, Republic of
Department of Plastic Surgery, Yonsei University School of Medicine, Severance Hospital Recruiting
Seoul, Korea, Republic of, 03722
Contact: Dongwon Lee, MD, Ph.D    82-2-2228-2215    XYPHOSS@yuhs.ac   
Sponsors and Collaborators
Yonsei University
Layout table for additonal information
Responsible Party: Yonsei University
ClinicalTrials.gov Identifier: NCT03535012    
Other Study ID Numbers: 4-2015-1019
First Posted: May 24, 2018    Key Record Dates
Last Update Posted: May 25, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No